Global Advanced Drug Delivery Systems Market 2024-2028
Advanced Drug Delivery Systems Market 2024-2028
The advanced drug delivery systems market is forecasted to grow by USD 225.6 bn during 2023-2028, accelerating at a CAGR of 13.3% during the forecast period. The report on the advanced drug delivery systems market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising chronic disease, rising investment in research and development of drug delivery, and rising healthcare expenditure globally.
Technavio's advanced drug delivery systems market is segmented as below:
By Type
- Oral
- Injection and inhalation
- Transdermal
- Carrier-based
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the advancements in nanotechnology as one of the prime reasons driving the advanced drug delivery systems market growth during the next few years. Also, rise of self-administration devices and growing development of biologics and biosimilars will lead to sizable demand in the market.
The report on the advanced drug delivery systems market covers the following areas:
- Advanced Drug Delivery Systems Market sizing
- Advanced Drug Delivery Systems Market forecast
- Advanced Drug Delivery Systems Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading advanced drug delivery systems market vendors that include 3M Co., Alfresa Holdings Corp., Alkermes Public Ltd. Co., AmerisourceBergen Corp., Antares Pharma Inc., Baxter International Inc., Bayer AG, Becton Dickinson and Co., Cardinal Health Inc., Endo International Plc, J M Smith Corp., NanoPass Technologies Ltd., Nektar Therapeutics, Perrigo Co. Plc, Philip Morris International Inc., Prodigy Health, Surmodics Inc., Teva Pharmaceutical Industries Ltd., UCB SA, and Ypsomed Holding AG. Also, the advanced drug delivery systems market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.